“third-rock-ventures” Archives

in
Entry Author Date Location
Decibel Hauls in $55M to Bring Multiple Hearing Drugs to the Clinic 06/19/18 Boston
Langer, Yancopoulos & Hockfield to Headline Xcelerate at Biotech Week Boston 06/07/18 Boston
Celsius Snags $65M to Harness Single-Cell Genomics for Drug Discovery 05/15/18 Boston
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
With $59M, Casma and Ex-Constellation CEO Take Aim at Cellular Trash 05/03/18 Boston
Third Rock’s Cedilla Launches with $56M for Protein Stability Drugs 04/24/18 Boston
Raising $56M, Revolution Medicines Drops Old Work and Turns to Cancer 04/24/18 San Francisco
Rheos Medicines Launches, Backed by $60M for Immunometabolism R&D 03/22/18 Boston
Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop 12/20/17 Boston
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Ex-Cubist CEO Bonney Emerges at Kaleido, Flagship’s Latest Microbiome Startup 09/18/17 Boston
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Magenta Nabs More Cash, Licenses Drug To Boost Transplant Pipeline 05/02/17 Boston
Frequency Nabs $32M, Will Push Hearing-Loss Drugs To Human Studies 04/11/17 Boston
Check Out What’s Hot in Boston Biotech on May 11: Saver Rate Ends Today 04/06/17 Boston
To Infinity and Beyond: Julian Adams on Missteps and His New Job 04/03/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
Harvard’s Verdine Aims to Retire, Become Full-Time FogPharma CEO 02/23/17 Boston
Rhythm Raises $41M to Bankroll Late-Stage Push For Obesity Drug 02/16/17 Boston
Biotech Leaders Sign Letter Condemning Trump’s Travel Ban 02/07/17 National
Foundation, Roche Deepen Ties as Genentech Vet Steps in for CEO Pellini 01/06/17 Boston
Neon Therapeutics Garners $70,000,000 Series B Round 01/06/17 Boston
Frequency, Led by MIT’s Langer, Aims to Fight Hearing Loss With Drugs 01/05/17 Boston
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines 01/05/17 Boston
First Trial Underway, Jounce Preps IPO To Fund Immuno-Oncology Work 01/03/17 Boston
REVOLUTION Medicines Garners $25,000,000 Series A Funding 12/22/16 San Francisco
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
Goldfinch Bio Obtains $55,000,000 Series A Round 12/15/16 Boston
Page 1 of 16 next page »